Search Results 561-570 of 17819 for testosterone

  1. Chemotherapy nausea and vomiting: Prevention is best defense - Mayo Clinic

    Testicular microlithiasis · Testosterone and prostate cancer: What's the connection? Throat cancer · Thyroid cancer · Treatment options for biliary tract cancer.

  2. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

    Serum testosterone < 50 ng/dL. Patients must continue primary ADT with an LHRH analogue (agonist or antagonist) if they have not undergone orchiectomy. Able ...

  3. Transsphenoidal surgery - Mayo Clinic

    Transsphenoidal, sometimes called transsphenoidal surgery, is a procedure to remove tumors from the pituitary gland and nearby areas in the skull base. The ...

  4. Prostate cancer - Doctors and departments - Mayo Clinic

    Prostate gland · Testosterone and prostate cancer · Transrectal biopsy of the prostate · Types of prostate cancer: Common and rare forms · What is prostate ...

  5. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  6. Publications - Joseph P. Grande, M.D., Ph.D. - Mayo Clinic

    Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-alpha ratio and attenuating T-cell infiltration ...

  7. A Study to Evaluate Bone Mineral Densities and Serological Markers to Assess Fracture Risk in Children and Young Adults with Bleeding Disorders - Mayo Clinic

    Use of medications known to impact bone and mineral metabolism (e.g., bisphosphonates, corticosteroids, estrogens, testosterone therapy, calcitonin, thyroid ...

  8. Prostate cancer - Doctors and departments - Mayo Clinic

    Prostate cancer: Does PSA level affect prognosis? Prostate gland · Testosterone and prostate cancer · Transrectal biopsy of the prostate · Types of prostate ...

  9. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    ... testosterone level ≤ 1.73 nmol/l (50 ng/dL) at screening visit. Individuals who have not had a bilateral orchiectomy must have a plan to maintain effective ...

  10. Idiopathic Erythrocytosis Impact on Patient Well-Being - Mayo Clinic

    Patients identified with secondary causes for erythrocytosis, including those who are using testosterone therapy or are active smokers with smoking identified ...